greeksoup/ stocks
Stocks / India / TORNTPHARM / Votes

Torrent Pharmaceuticals Ltd. shareholder votes

The exchange lists 6 meetings for Torrent Pharmaceuticals Ltd. with 20 resolutions put to shareholders; 0 failed and 0 passed with 10 percent or more against. The latest, a postal ballot on 6 September 2026, put 1 resolution to the vote, the lowest support 99.98% for.

MeetingResolutionKindForAgainstFiling
Postal Ballot, 6 September 2026Appointment of Shanti Ekambaram as an Independent Director of the CompanySpecial99.98%0.02%NSE
AGM, 23 June 2026To receive, consider and adopt the Standalone Financial Statements as at 31st March, 2026 including the Audited Balance Sheet as at 31st March, 2026, the Statement of Profit and Loss for the year ended on that date and reports of the Board of Directors and Auditors thereon.Ordinary100.00%0.00%NSE
AGM, 23 June 2026Issuance of Equity Shares Including Convertible Bonds / DebenturesSpecial99.93%0.07%NSE
AGM, 23 June 2026Ratification of Remuneration of Cost Auditors of the Company for the year 2026-27.Ordinary100.00%0.00%NSE
AGM, 23 June 2026To appoint a Director in place of Samir Mehta (holding DIN: 00061903), Director, who retires by rotation and being eligible, offers himself for re-appointment.Ordinary98.74%1.26%NSE
AGM, 23 June 2026To confirm the payment of interim dividend of Rs 29.00 per equity share of fully paid up face value of Rs 5.00 each already paid during the financial year ended 31st March, 2026 and to declare final dividend of Rs 9.00 per equity share of fully paid up face value of Rs 5.00 each for the financial year ended on 31st March, 2026.Ordinary100.00%0.00%NSE
AGM, 23 June 2026To receive, consider and adopt the Consolidated Financial Statements as at 31st March, 2026 including the Audited Balance Sheet as at 31st March, 2026, the Statement of Profit and Loss for the year ended on that date and reports of the Auditors thereon.Ordinary100.00%0.00%NSE
AGM, 23 June 2026Issuance of Equity Shares Including Convertible Bonds / DebenturesSpecial99.93%0.07%NSE
AGM, 23 June 2026Ratification of Remuneration of Cost Auditors of the Company for the year 2026-27.Ordinary100.00%0.00%NSE
AGM, 23 June 2026To appoint a Director in place of Samir Mehta (holding DIN: 00061903), Director, who retires by rotation and being eligible, offers himself for re-appointment.Ordinary98.74%1.26%NSE
AGM, 23 June 2026To confirm the payment of interim dividend of Rs 29.00 per equity share of fully paid up face value of Rs 5.00 each already paid during the financial year ended 31st March, 2026 and to declare final dividend of Rs 9.00 per equity share of fully paid up face value of Rs 5.00 each for the financial year ended on 31st March, 2026.Ordinary100.00%0.00%NSE
AGM, 23 June 2026To receive, consider and adopt the Consolidated Financial Statements as at 31st March, 2026 including the Audited Balance Sheet as at 31st March, 2026, the Statement of Profit and Loss for the year ended on that date and reports of the Auditors thereon.Ordinary100.00%0.00%NSE
AGM, 23 June 2026To receive, consider and adopt the Standalone Financial Statements as at 31st March, 2026 including the Audited Balance Sheet as at 31st March, 2026, the Statement of Profit and Loss for the year ended on that date and reports of the Board of Directors and Auditors thereon.Ordinary100.00%0.00%NSE
Court Convened Meeting, 28 April 2026To consider and approve the proposed Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited (“Transferor Company” or “JB Pharma”) with Torrent Pharmaceuticals Limited (“Company” or “Transferee Company” or “Torrent Pharma”) and their respective shareholders (“Scheme”)Special100.00%0.00%NSE
Court Convened Meeting, 28 April 2026To consider and approve the proposed Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited (“Transferor Company” or “JB Pharma”) with Torrent Pharmaceuticals Limited (“Company” or “Transferee Company” or “Torrent Pharma”) and their respective shareholders (“Scheme”)Special100.00%0.00%NSE
AGM, 28 July 2025To receive, consider and adopt the Standalone Financial Statements as at 31st March, 2025 including the Audited Balance Sheet as at 31st March, 2025, the Statement of Profit and Loss for the year ended on that date and reports of the Board of Directors and Auditors thereon.Ordinary99.58%0.42%NSE
AGM, 28 July 2025Ratification of Remuneration of Cost Auditors of the Company for the year 2025-26.Ordinary100.00%0.00%NSE
AGM, 28 July 2025To appoint a Director in place of Aman Mehta (holding DIN: 08174906), Director, who retires by rotation and being eligible, offers himself for re-appointment.Ordinary99.94%0.06%NSE
AGM, 28 July 2025To confirm the payment of interim dividend of Rs 26.00 per equity share of fully paid up face value of rs 5.00 each already paid during the financial year ended 31st March, 2025 and to declare final dividend of rs 6.00 per equity share of fully paid up face value of rs 5.00 each for the financial year ended on 31st March, 2025.Ordinary100.00%0.00%NSE
AGM, 28 July 2025To receive, consider and adopt the Consolidated Financial Statements as at 31st March, 2025 including the Audited Balance Sheet as at 31st March, 2025, the Statement of Profit and Loss for the year ended on that date and reports of the Auditors thereon.Ordinary99.58%0.42%NSE

An ordinary resolution passes with more than half the votes cast, a special resolution with more than three quarters. Percentages are the totals the company reported to the exchange across all shareholder classes. The exchange's list carries recent meetings, not the whole history.

Source

Voting results on nseindia.com for TORNTPHARM.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install